Developing the Blueprint for a Genetic Testing Registry

被引:18
作者
Javitt, G. [1 ]
Katsanis, S. [1 ]
Scott, J. [1 ]
Hudson, K. [1 ]
机构
[1] Johns Hopkins Univ, Genet & Publ Policy Ctr, Berman Bioeth Inst, Washington, DC 20036 USA
基金
美国国家卫生研究院;
关键词
Clinical genetics; Genetic testing; Policy; Registry;
D O I
10.1159/000226593
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
While the number of genetic tests continues to grow, publicly accessible information about the analytic and clinical validity of such tests is lagging. Information gaps impede informed decision making by health care providers and patients. Enhancing the transparency of information about what tests are being offered, for which indications tests are being offered, and the analytic and clinical validity of tests is a key prerequisite to ensuring test quality. A recent government recommendation for a mandatory genetic test registry has received wide stakeholder support but leaves many practical questions unanswered. We propose a 'blueprint' for the creation of a genetic test registry in order to expedite its implementation. We describe the goals of a registry, propose criteria for the inclusion of registrants and tests in the registry, and define the categories of information that should be included for such tests. We discuss the sources of legal authority that empower the government to mandate that a registry be established and identify the federal agencies with the relevant expertise and resources to do so. We conclude that establishing a registry is a critical first step in the development of a more transparent, quality-centered system of oversight that will better inform and protect the public. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:95 / 105
页数:11
相关论文
共 41 条
[1]  
Agency for Healthcare Research and Quality, 2007, AHRQ PUBL
[2]   Development and integration of molecular genetic tests into clinical practice: the US experience [J].
Amos, J ;
Grady, W .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2004, 4 (04) :465-477
[3]  
[Anonymous], NUTR TEST TESTS PURC
[4]  
[Anonymous], FED REG 1121
[5]  
*CDCP, 2008, ASS REPR TECHN
[6]   Molecular genetic testing for ultra rare diseases: models for translation from the research laboratory to the CLIA-certified diagnostic laboratory [J].
Das, S. ;
Bale, Sherri J. ;
Ledbetter, David H. .
GENETICS IN MEDICINE, 2008, 10 (05) :332-336
[7]  
*EDDNAL, 2008, WELC EDDNAL EUR DICT
[8]  
*EUROGENTEST, 2008, HARM GEN TEST EUR
[9]  
Food and Drug Administration, 2002, GUID IND EST PREGN E
[10]  
Food and Drug Administration, 2007, GUID IND FDA STAFF P